La farmacéutica india Lupin quiere comprar compañías en Latinoamérica
Intel ID : 210391
|
Synopsis
01 JUL 2013
|
|
(content in spanish)
La compañía india Lupin ha puesto su punto de mira en Latinoamérica, donde espera realizar próximamente la compra de alguna compañía del sector farmacéutico, especialmente en México, Brasil, Argentina o Chile. Estas posibles adquisiciones forman parte de la estrategia de expansión e internacionalización de la compañía para los próximos años. |
|
||||
| Intel ID | 210391 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
|
Financial Data - Lupin
(31 Dec 2013) |
Revenue: - EBITDA: - |
|
| Date |
|
|
| Country |  |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Website |
|
||
| Description |
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
|
|
|
 |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.